---
figid: PMC6858516__nihms-1054030-f0003
figlink: /pmc/articles/PMC6858516/figure/F3/
number: F3
caption: Genomic alterations involving the PTEN-PI3K-AKT pathway occur in ~50% of
  metastatic castration-resistant prostate cancers (mCRPCs) resulting in PI3K-AKT
  pathway activation. Loss of PTEN has been associated with shorter time on androgen
  receptor (AR) pathway inhibitor (ARPI) treatment potentially due to reciprocal negative
  feedback of the PI3K and AR signalling pathways. Drugs that target AKT or PI3K inhibitors
  are currently being tested in clinical trials as monotherapy (for AKT-mutated tumours)
  or in combination with ARPIs. A, androgen; ABI, abiraterone; AKTi, AKT inhibitor;
  FKBP5, FK506 binding protein 5; PHLPP, PH domain leucine-rich repeat protein phosphatase;
  Ptdlns(4,5)P2, phosphatidylinositol 4,5-bisphosphate; Ptdlns(3,4,5)P3, phosphatidylinositol
  3,4,5-trisphosphate; RTK, receptor tyrosine kinase.
pmcid: PMC6858516
papertitle: Towards precision oncology in advanced prostate cancer.
reftext: Sheng-Yu Ku, et al. Nat Rev Urol. ;16(11):645-654.
pmc_ranked_result_index: '13708'
pathway_score: 0.9765834
filename: nihms-1054030-f0003.jpg
figtitle: Towards precision oncology in advanced prostate cancer
year: ''
organisms: Homo sapiens
ndex: 71282ee3-debf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6858516__nihms-1054030-f0003.html
  '@type': Dataset
  description: Genomic alterations involving the PTEN-PI3K-AKT pathway occur in ~50%
    of metastatic castration-resistant prostate cancers (mCRPCs) resulting in PI3K-AKT
    pathway activation. Loss of PTEN has been associated with shorter time on androgen
    receptor (AR) pathway inhibitor (ARPI) treatment potentially due to reciprocal
    negative feedback of the PI3K and AR signalling pathways. Drugs that target AKT
    or PI3K inhibitors are currently being tested in clinical trials as monotherapy
    (for AKT-mutated tumours) or in combination with ARPIs. A, androgen; ABI, abiraterone;
    AKTi, AKT inhibitor; FKBP5, FK506 binding protein 5; PHLPP, PH domain leucine-rich
    repeat protein phosphatase; Ptdlns(4,5)P2, phosphatidylinositol 4,5-bisphosphate;
    Ptdlns(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; RTK, receptor tyrosine
    kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - AKT2
  - AR
  - FKBP5
  - ERBB2
  - ERBB3
  - MTOR
  - RPTOR
  - PHLPP1
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PTEN
  - Ptdlns(4,5)P
  - PtdIns(3,4,5)P
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: FKBP5
  symbol: FKBP5
  source: hgnc_symbol
  hgnc_symbol: FKBP5
  entrez: '2289'
- word: HER2/
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: mTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: mTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PHLPP
  symbol: PHLPP
  source: hgnc_prev_symbol
  hgnc_symbol: PHLPP1
  entrez: '23239'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals:
- word: Ptdlns(4,5)P
  source: MESH
  identifier: D010695
- word: PtdIns(3,4,5)P
  source: MESH
  identifier: D010716
diseases: []
figid_alias: PMC6858516__F3
redirect_from: /figures/PMC6858516__F3
figtype: Figure
---
